Trait centric view

1. Trait name:	Stillbirth
   Ontology terms:	VT:1000197

   253 genes are associated with this trait, with QTL/association found

   • ABCC1: ATP binding cassette subfamily C member 1
     evidenced by: QTL:52528;
   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:41432; QTL:41437;
   • ABHD2: Abhydrolase domain containing 2, acylglycerol lipase
     evidenced by: QTL:51098;
   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45081;
   • ACTE1: Actin epsilon 1
     evidenced by: QTL:53998; QTL:54007;
   • ADAM10: ADAM metallopeptidase domain 10
     evidenced by: QTL:44753;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53546;
   • ADAMTS16: ADAM metallopeptidase with thrombospondin type 1 motif 16
     evidenced by: QTL:50949;
   • ADAMTS17: ADAM metallopeptidase with thrombospondin type 1 motif 17
     evidenced by: QTL:50969;
   • ADCY5: Adenylate cyclase 5
     evidenced by: QTL:38481;
   • AKAP6: A-kinase anchoring protein 6
     evidenced by: QTL:51221; QTL:51227;
   • AKT3: AKT serine/threonine kinase 3
     evidenced by: QTL:48279;
   • ANGPT1: Angiopoietin 1
     evidenced by: QTL:47663; QTL:47668;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50020;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42326;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:42055;
   • APH1B: Aph-1 homolog B, gamma-secretase subunit
     evidenced by: QTL:44737;
   • ARHGAP22: Rho GTPase activating protein 22
     evidenced by: QTL:53858;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43070; QTL:43088;
   • ARHGEF9: Cdc42 guanine nucleotide exchange factor 9
     evidenced by: QTL:54841;
   • ARPIN: Actin related protein 2/3 complex inhibitor
     evidenced by: QTL:51122;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53328;
   • ATP1A3: ATPase Na+/K+ transporting subunit alpha 3
     evidenced by: QTL:49740;
   • AURKA: Aurora kinase A
     evidenced by: QTL:47324;
   • AZIN1: Antizyme inhibitor 1
     evidenced by: QTL:47678;
   • BAG2: BAG cochaperone 2
     evidenced by: QTL:51925;
   • BCR: BCR activator of RhoGEF and GTPase
     evidenced by: QTL:49430;
   • BDP1: B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
     evidenced by: QTL:50522; QTL:50533;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:51981;
   • BOSTAUV1R416: Vomeronasal 1 receptor bosTauV1R416
     evidenced by: QTL:147065;
   • BSND: Barttin CLCNK type accessory subunit beta
     evidenced by: QTL:40135;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41132;
   • BUB3: BUB3 mitotic checkpoint protein
     evidenced by: QTL:53062; QTL:53067;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49661; QTL:49674;
   • CACHD1: Cache domain containing 1
     evidenced by: QTL:39957;
   • CACNA2D3: Calcium voltage-gated channel auxiliary subunit alpha2delta 3
     evidenced by: QTL:51804; QTL:51811;
   • CACNG5: Calcium voltage-gated channel auxiliary subunit gamma 5
     evidenced by: QTL:50277;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40609; QTL:40615; QTL:40632;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44612;
   • CC2D1A: Coiled-coil and C2 domain containing 1A
     evidenced by: QTL:42721; QTL:42730;
   • CCDC69: Coiled-coil domain containing 69
     evidenced by: QTL:43222;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41339;
   • CDC42BPB: CDC42 binding protein kinase beta
     evidenced by: QTL:51484;
   • CDH6: Cadherin 6
     evidenced by: QTL:50298;
   • CEP70: Centrosomal protein 70
     evidenced by: QTL:38832;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39114;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:52825;
   • CLDN1: Claudin 1
     evidenced by: QTL:38486;
   • CNKSR3: CNKSR family member 3
     evidenced by: QTL:44285;
   • CNTN5: Contactin 5
     evidenced by: QTL:47793;
   • COL12A1: Collagen type XII alpha 1 chain
     evidenced by: QTL:51956;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54602;
   • COL6A1: Collagen type VI alpha 1 chain
     evidenced by: QTL:38930; QTL:38939;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:40669;
   • CPAMD8: C3 and PZP like alpha-2-macroglobulin domain containing 8
     evidenced by: QTL:42676;
   • CPEB3: Cytoplasmic polyadenylation element binding protein 3
     evidenced by: QTL:52665; QTL:52675;
   • CPQ: Carboxypeptidase Q
     evidenced by: QTL:47681;
   • CPSF3: Cleavage and polyadenylation specific factor 3
     evidenced by: QTL:46023;
   • CREB3L1: CAMP responsive element binding protein 3 like 1
     evidenced by: QTL:48003;
   • CRTC1: CREB regulated transcription coactivator 1
     evidenced by: QTL:42635;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:40838;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53770;
   • CTU1: Cytosolic thiouridylase subunit 1
     evidenced by: QTL:147050; QTL:147060;
   • CUL2: Cullin 2
     evidenced by: QTL:46809; QTL:46821;
   • DAB1: DAB adaptor protein 1
     evidenced by: QTL:40063;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46336;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38502;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53101;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53122;
   • DOT1L: DOT1 like histone lysine methyltransferase
     evidenced by: QTL:42849; QTL:42860;
   • DSCAM: DS cell adhesion molecule
     evidenced by: QTL:38920; QTL:38926;
   • DTNA: Dystrobrevin alpha
     evidenced by: QTL:52361;
   • EIF2B3: Eukaryotic translation initiation factor 2B subunit gamma
     evidenced by: QTL:40195;
   • ENTHD1: ENTH domain containing 1
     evidenced by: QTL:41612;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44105;
   • EPHB1: EPH receptor B1
     evidenced by: QTL:38839; QTL:38845; QTL:38850; QTL:38857; QTL:38862; QTL:38867;
   • ESR1: Estrogen receptor 1
     evidenced by: QTL:44273;
   • EXOC4: Exocyst complex component 4
     evidenced by: QTL:40681;
   • EXT1: Exostosin glycosyltransferase 1
     evidenced by: QTL:47625;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49448;
   • FAM134B: Family with sequence similarity 134 member B
     evidenced by: QTL:50908;
   • FAS: Fas (TNF receptor superfamily, member 6)
     evidenced by: QTL:52652;
   • FAT3: FAT atypical cadherin 3
     evidenced by: QTL:53868; QTL:53885; QTL:53896;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51401;
   • FCAR: Fc fragment of IgA receptor
     evidenced by: QTL:147051;
   • FCHO1: FCH and mu domain containing endocytic adaptor 1
     evidenced by: QTL:42670;
   • FER1L5: Fer-1 like family member 5
     evidenced by: QTL:45091;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51687; QTL:51707; QTL:51714; QTL:51728; QTL:51743;
   • FLNB: Filamin B
     evidenced by: QTL:51781;
   • FLT4: Fms related receptor tyrosine kinase 4
     evidenced by: QTL:42616; QTL:42629;
   • FNDC3B: Fibronectin type III domain containing 3B
     evidenced by: QTL:38643;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51354; QTL:51361; QTL:51369;
   • FRMD6: FERM domain containing 6
     evidenced by: QTL:44727;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:41527;
   • GABRR3: Gamma-aminobutyric acid type A receptor rho3 subunit
     evidenced by: QTL:38362;
   • GARIN2: Golgi associated RAB2 interactor family member 2
     evidenced by: QTL:44955;
   • GARS1: Glycyl-tRNA synthetase 1
     evidenced by: QTL:40445;
   • GOLT1A: Golgi transport 1A
     evidenced by: QTL:48054; QTL:48061;
   • GPHN: Gephyrin
     evidenced by: QTL:44949;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54164; QTL:54197;
   • GRIK2: Glutamate ionotropic receptor kainate type subunit 2
     evidenced by: QTL:44005;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49694;
   • GSTO2: Glutathione S-transferase omega 2
     evidenced by: QTL:52840;
   • GTDC1: Glycosyltransferase like domain containing 1
     evidenced by: QTL:39438;
   • HCRTR2: Hypocretin receptor 2
     evidenced by: QTL:51986;
   • HHAT: Hedgehog acyltransferase
     evidenced by: QTL:48491;
   • HMCN1: Hemicentin 1
     evidenced by: QTL:48417;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45984;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:52758; QTL:52770; QTL:52783;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:47972;
   • HSD17B14: Hydroxysteroid 17-beta dehydrogenase 14
     evidenced by: QTL:49847; QTL:49859;
   • IGSF5: Immunoglobulin superfamily member 5
     evidenced by: QTL:38908; QTL:38915;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54533;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:46037;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51434;
   • JAK1: Janus kinase 1
     evidenced by: QTL:39917; QTL:39929; QTL:39937; QTL:39950;
   • JPH2: Junctophilin 2
     evidenced by: QTL:47358;
   • KCNC3: Potassium voltage-gated channel subfamily C member 3
     evidenced by: QTL:147048;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50349;
   • KCNT1: Potassium sodium-activated channel subfamily T member 1
     evidenced by: QTL:46120;
   • KHDRBS2: KH RNA binding domain containing, signal transduction associated 2
     evidenced by: QTL:51879;
   • KIF26B: Kinesin family member 26B
     evidenced by: QTL:48264;
   • KLHL1: Kelch like family member 1
     evidenced by: QTL:46319;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47849;
   • LEP: Leptin
     evidenced by: QTL:11625; QTL:11626; QTL:13019; QTL:13020;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42553;
   • LIN7A: Lin-7 homolog A, crumbs cell polarity complex component
     evidenced by: QTL:40747; QTL:40751; QTL:40764;
   • LIPT2: Lipoyl(octanoyl) transferase 2
     evidenced by: QTL:47920;
   • LMO7: LIM domain 7
     evidenced by: QTL:46418;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:42209;
   • LRBA: LPS responsive beige-like anchor protein
     evidenced by: QTL:48664; QTL:48667; QTL:48673; QTL:48684; QTL:48689;
   • LRFN2: Leucine rich repeat and fibronectin type III domain containing 2
     evidenced by: QTL:52047; QTL:52055;
   • MAML3: Mastermind like transcriptional coactivator 3
     evidenced by: QTL:48982;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54926;
   • MBNL3: Muscleblind like splicing regulator 3
     evidenced by: QTL:54324;
   • MEF2C: Myocyte enhancer factor 2C
     evidenced by: QTL:43358;
   • METTL15: Methyltransferase like 15
     evidenced by: QTL:47948;
   • MFGE8: Milk fat globule-EGF factor 8 protein
     evidenced by: QTL:51088;
   • MGAT4C: MGAT4 family member C
     evidenced by: QTL:40797;
   • MGMT: O-6-methylguanine-DNA methyltransferase
     evidenced by: QTL:53252; QTL:53264;
   • MGP: Matrix Gla protein
     evidenced by: QTL:41513;
   • MINAR2: Membrane integral NOTCH2 associated receptor 2
     evidenced by: QTL:42893;
   • MLXIP: MLX interacting protein
     evidenced by: QTL:49344; QTL:49349;
   • MND1: Meiotic nuclear divisions 1
     evidenced by: QTL:48582; QTL:48588;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:52014;
   • MSGN1: Mesogenin 1
     evidenced by: QTL:45662;
   • MYBL2: MYB proto-oncogene like 2
     evidenced by: QTL:47356;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46543;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:45733; QTL:45738; QTL:45751;
   • NCSTN: Nicastrin
     evidenced by: QTL:39724;
   • NDP: Norrin cystine knot growth factor NDP
     evidenced by: QTL:54910;
   • NDUFAF1: NADH:ubiquinone oxidoreductase complex assembly factor 1
     evidenced by: QTL:44522;
   • NELFA: Negative elongation factor complex member A
     evidenced by: QTL:42591;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41684;
   • NFIX: Nuclear factor I X
     evidenced by: QTL:42760; QTL:42773;
   • NHS: NHS actin remodeling regulator
     evidenced by: QTL:55240;
   • NHSL1: NHS like 1
     evidenced by: QTL:44147;
   • NIN: Ninein
     evidenced by: QTL:44715;
   • NOX4: NADPH oxidase 4
     evidenced by: QTL:53914;
   • NPR3: Natriuretic peptide receptor 3
     evidenced by: QTL:50772;
   • NRF1: Nuclear respiratory factor 1
     evidenced by: QTL:40650; QTL:40655;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53830;
   • NRP1: Neuropilin 1
     evidenced by: QTL:46886; QTL:46896;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41063;
   • NYAP2: Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
     evidenced by: QTL:39555;
   • OAZ1: Ornithine decarboxylase antizyme 1
     evidenced by: QTL:42837; QTL:42845;
   • PACSIN1: Protein kinase C and casein kinase substrate in neurons 1
     evidenced by: QTL:52000;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:41023;
   • PARD3: Par-3 family cell polarity regulator
     evidenced by: QTL:46835; QTL:46838; QTL:46852; QTL:46866; QTL:46882;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53788;
   • PCDHA13: Protocadherin alpha 13
     evidenced by: QTL:43053;
   • PCIF1: Phosphorylated CTD interacting factor 1
     evidenced by: QTL:47378;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:40819;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50702; QTL:50722;
   • PDGFRB: Platelet derived growth factor receptor beta
     evidenced by: QTL:43186;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39739;
   • PEG3: Paternally expressed 3
     evidenced by: QTL:13530;
   • PGF: Placental growth factor
     evidenced by: QTL:125749; QTL:125751; QTL:125753; QTL:125755; QTL:125757; QTL:125759; QTL:125761; QTL:125763; QTL:125765; QTL:125767; QTL:125769; QTL:125771;
   • PHEX: Phosphate regulating endopeptidase homolog X-linked
     evidenced by: QTL:55159; QTL:55173;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43727;
   • PLA2G4F: Phospholipase A2 group IVF
     evidenced by: QTL:44568;
   • PLCH1: Phospholipase C eta 1
     evidenced by: QTL:38692;
   • PRIM2: DNA primase subunit 2
     evidenced by: QTL:51903;
   • PRKD1: Protein kinase D1
     evidenced by: QTL:51181; QTL:51194; QTL:51208;
   • PRLHR: Prolactin releasing hormone receptor
     evidenced by: QTL:52919;
   • RAD51: RAD51 recombinase
     evidenced by: QTL:44477;
   • RASGRP3: RAS guanyl releasing protein 3
     evidenced by: QTL:45188;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:42041;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41107;
   • RMND5B: Required for meiotic nuclear division 5 homolog B
     evidenced by: QTL:42994;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45905; QTL:45926;
   • ROR1: Receptor tyrosine kinase like orphan receptor 1
     evidenced by: QTL:39970; QTL:39979;
   • RPS6KC1: Ribosomal protein S6 kinase C1
     evidenced by: QTL:48471;
   • RTF1: RTF1 homolog, Paf1/RNA polymerase II complex component
     evidenced by: QTL:44532;
   • RUNX1: RUNX family transcription factor 1
     evidenced by: QTL:38957; QTL:38964;
   • SCARF1: Scavenger receptor class F member 1
     evidenced by: QTL:50039;
   • SDCCAG8: SHH signaling and ciliogenesis regulator SDCCAG8
     evidenced by: QTL:48281;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41861;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43976;
   • SECISBP2: SECIS binding protein 2
     evidenced by: QTL:43759;
   • SERINC3: Serine incorporator 3
     evidenced by: QTL:47360;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52466;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52986;
   • SGTA: Small glutamine rich tetratricopeptide repeat co-chaperone alpha
     evidenced by: QTL:42820;
   • SH2D2A: SH2 domain containing 2A
     evidenced by: QTL:39743;
   • SHANK2: SH3 and multiple ankyrin repeat domains 2
     evidenced by: QTL:53982;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48708; QTL:48719;
   • SLC24A4: Solute carrier family 24 member 4
     evidenced by: QTL:51412;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39088;
   • SLC35D2: Solute carrier family 35 member D2
     evidenced by: QTL:43708; QTL:43713;
   • SLC39A10: Solute carrier family 39 member 10
     evidenced by: QTL:39481;
   • SLC8A3: Solute carrier family 8 member A3
     evidenced by: QTL:44966;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:41456;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50326;
   • SMARCA5: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
     evidenced by: QTL:48838;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39601;
   • SPATA45: Spermatogenesis associated 45
     evidenced by: QTL:48476;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43020; QTL:43037;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41627;
   • SUN2: Sad1 and UNC84 domain containing 2
     evidenced by: QTL:41582;
   • SUSD4: Sushi domain containing 4
     evidenced by: QTL:48259;
   • SYN2: Synapsin II
     evidenced by: QTL:51856;
   • SYN3: Synapsin III
     evidenced by: QTL:41180; QTL:41212; QTL:41217;
   • SYT3: Synaptotagmin 3
     evidenced by: QTL:49877;
   • SYTL5: Synaptotagmin like 5
     evidenced by: QTL:54986;
   • TASP1: Taspase 1
     evidenced by: QTL:46759;
   • TBC1D12: TBC1 domain family member 12
     evidenced by: QTL:52693;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48969;
   • TBCD: Tubulin folding cofactor D
     evidenced by: QTL:50071;
   • TCF20: Transcription factor 20
     evidenced by: QTL:41670;
   • TENM2: Teneurin transmembrane protein 2
     evidenced by: QTL:43312;
   • TGM7: Transglutaminase 7
     evidenced by: QTL:51301; QTL:51307;
   • TM9SF2: Transmembrane 9 superfamily member 2
     evidenced by: QTL:46521; QTL:46528;
   • TMC5: Transmembrane channel like 5
     evidenced by: QTL:52541;
   • TMEM61: Transmembrane protein 61
     evidenced by: QTL:40143;
   • TPCN1: Two pore segment channel 1
     evidenced by: QTL:49396;
   • TRABD2B: TraB domain containing 2B
     evidenced by: QTL:40172;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:47478; QTL:47490;
   • TRIM68: Tripartite motif containing 68
     evidenced by: QTL:47903;
   • TSPAN32: Tetraspanin 32
     evidenced by: QTL:13549;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53612;
   • USP13: Ubiquitin specific peptidase 13
     evidenced by: QTL:38580;
   • UVRAG: UV radiation resistance associated
     evidenced by: QTL:47922; QTL:47925;
   • VWA8: Von Willebrand factor A domain containing 8
     evidenced by: QTL:46202;
   • WDR17: WD repeat domain 17
     evidenced by: QTL:53312;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47309;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40975;
   • ZIM2: Zinc finger, imprinted 2
     evidenced by: QTL:13537; QTL:13538; QTL:13539;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52186;
   • ZNF280C: Zinc finger protein 280C
     evidenced by: QTL:54304;
   • ZNF335: Zinc finger protein 335
     evidenced by: QTL:47392;
   • ZNF407: Zinc finger protein 407
     evidenced by: QTL:52275;
   • ZNF592: Zinc finger protein 592
     evidenced by: QTL:51134; QTL:51145;
   46 correlations are found involving Stillbirth